Byelyankacin: A novel melanogenesis inhibitor produced by Enterobacter sp. B20

Senji Takahashi, Hiroki Iwai, Kunio Kosaka, Toshitsugu Miyazaki, Yuko Osanai, Nakako Arao, Kouichi Tanaka, Koji Nagai, Akira Nakagawa

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

A novel melanogenesis inhibitor, byelyankacin (1), was isolated from the fermentation broth of a bacterial strain. The producing organism, designated B20, was identified as a member of the genus Enterobacter based on taxonomic characteristics. 1 was obtained as a white powder from the culture medium by solvent extraction and serial chromatographic purification. The structure of 1 was determined as (E)-4-(2-isocyanovinyl)phenyl α-L-rhamnopyranoside on the basis of spectroscopic data. 1 potently inhibited mushroom tyrosinase and melanogenesis of B16-2D2 melanoma cells with IC50 value of 2.1 nM and 30 nM, respectively.

Original languageEnglish
Pages (from-to)717-720
Number of pages4
JournalJournal of Antibiotics
Volume60
Issue number11
DOIs
StatePublished - Nov 2007

Keywords

  • B16-2D2 melanoma cell
  • Byelyankacin
  • Enterobacter sp.
  • Melanogenesis inhibitor
  • Mushroom tyrosinase

Fingerprint

Dive into the research topics of 'Byelyankacin: A novel melanogenesis inhibitor produced by Enterobacter sp. B20'. Together they form a unique fingerprint.

Cite this